Kidney Transplant Rejection Recruiting Phase 4 Trials for Tacrolimus (DB00864)

Also known as: Kidney transplant rejection / Renal Transplant Rejection / Acute allograft nephropathy

IndicationStatusPhase
DBCOND0066662 (Kidney Transplant Rejection)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02866682Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant RecipientsTreatment
NCT03511560Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney TransplantationPrevention
NCT04225988Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in HLA Sensitized Kidney Transplant RecipientsTreatment